Search results
Showing 31 to 45 of 45 results for uterine fibroid
Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126)
This guideline covers diagnosing and managing ectopic pregnancy and miscarriage in women with complications, such as pain and bleeding, in early pregnancy (that is, up to 13 completed weeks of pregnancy). It aims to improve how early pregnancy loss is diagnosed, and the support women are given, to limit the psychological impact of their loss.
Hysteroscopic morcellation of uterine leiomyomas (fibroids) (IPG522)
This guidance has been updated and replaced by NICE interventional procedures guidance 704.
Interventional procedures, IPG367 - Issued: November 2010 --> We have moved interventional procedures guidance 367 to become HealthTech guidance 240. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This guidance has been updated and replaced by NICE interventional procedures guidance 522.
This guidance has been updated and replaced by NICE HealthTech guidance 240.
This guidance has been updated and replaced by NICE HealthTech guidance 240.
Laparoscopic removal of uterine fibroids with power morcellation (IPG703)
We have moved interventional procedures guidance 703 to become HealthTech guidance 589. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids (IPG689)
We have moved interventional procedures guidance 689 to become HealthTech guidance 572. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids (IPG704)
We have moved interventional procedures guidance 704 to become HealthTech guidance 590. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids (IPG413)
Interventional procedures, IPG413 - Issued: November 2011 --> We have moved interventional procedures guidance 413 to become HealthTech guidance 277. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids (IPG231)
This guidance has been updated and replaced by NICE HealthTech guidance 277.
Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids (IPG30)
We have moved interventional procedures guidance 30 to become HealthTech guidance 12. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved interventional procedures guidance 657 to become HealthTech guidance 523. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Up to 1,000 women a year could benefit from new at-home treatment for endometriosis
Today we've recommended a new treatment option for symptoms of endometriosis that can be taken at home.
Thousands could benefit from new option for treating symptoms of uterine fibroids
As many as 30,000 adults could benefit from a new treatment for moderate to severe symptoms of uterine fibroids after we published final guidance today (14 August 2024) recommending linzagolix.